ipamorelin risks clinical trial safety growth hormone secretagogue What are the considerations and potential for using The hidden risks of grey-market
Description
doi: 10.1016/j.jaci.2010.03.008

Compter I, Eekers DBP, Hoeben A, Rouschop KMA, Reymen B, Ackermans L, et al
von Ahsen, N., Oellerich, M

C.Motta-SantosD.AleninaN.BaderM.et al (2018)
